Monstarlab Inc. (TYO:5255)
Japan · Delayed Price · Currency is JPY 94.00
+8.00 (9.30%)
Jun 5, 2026, 9:53 AM JST
Monstarlab Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,849 | 7,795 | 10,003 | 13,346 | 14,270 | 9,346 | |
Revenue Growth (YoY) | -10.02% | -22.07% | -25.05% | -6.48% | 52.69% | 25.97% |
Cost of Revenue | 4,721 | 4,646 | 8,578 | 10,006 | 9,326 | 6,418 |
Gross Profit | 3,128 | 3,149 | 1,425 | 3,340 | 4,944 | 2,928 |
Selling, General & Admin | 2,531 | 2,532 | 5,097 | 6,134 | 5,627 | 4,245 |
Other Operating Expenses | -75.42 | -64 | -449 | 139 | -294 | 1,906 |
Operating Expenses | 2,540 | 2,553 | 6,771 | 6,335 | 5,333 | 6,151 |
Operating Income | 588.26 | 596 | -5,346 | -2,995 | -389 | -3,223 |
Interest Expense | - | -141 | -161 | -92 | -130 | -75 |
Interest & Investment Income | 108.26 | 2 | 50 | 3 | 72 | 208 |
Earnings From Equity Investments | -43.54 | -61 | -37 | - | - | - |
Currency Exchange Gain (Loss) | 69 | 69 | 573 | -8 | - | - |
Other Non Operating Income (Expenses) | 7 | 7 | - | 14 | 1 | 1 |
EBT Excluding Unusual Items | 728.98 | 472 | -4,921 | -3,078 | -446 | -3,089 |
Gain (Loss) on Sale of Investments | -719 | -719 | -684 | 938 | - | - |
Gain (Loss) on Sale of Assets | - | - | - | -2 | - | - |
Asset Writedown | -72 | -72 | -4,240 | -15 | - | - |
Pretax Income | -62.02 | -319 | -9,845 | -2,157 | -446 | -3,089 |
Income Tax Expense | 95.6 | 39 | 133 | 163 | 276 | -1 |
Earnings From Continuing Operations | -157.62 | -358 | -9,978 | -2,320 | -722 | -3,088 |
Net Income to Company | - | -358 | -9,978 | -2,320 | -722 | -3,088 |
Minority Interest in Earnings | 13.46 | 21 | 31 | -35 | 48 | 35 |
Net Income | -144.15 | -337 | -9,947 | -2,355 | -674 | -3,053 |
Preferred Dividends & Other Adjustments | 86.92 | 86.92 | - | - | - | - |
Net Income to Common | -231.08 | -423.92 | -9,947 | -2,355 | -674 | -3,053 |
Shares Outstanding (Basic) | 62 | 57 | 35 | 34 | 28 | 27 |
Shares Outstanding (Diluted) | 62 | 57 | 35 | 34 | 28 | 27 |
Shares Change (YoY) | 26.11% | 62.48% | 3.80% | 22.08% | 2.06% | 18.31% |
EPS (Basic) | -3.74 | -7.48 | -285.08 | -70.06 | -24.48 | -113.17 |
EPS (Diluted) | -3.74 | -7.48 | -285.10 | -70.07 | -24.51 | -113.17 |
Free Cash Flow | 251.91 | -164 | -3,130 | -3,639 | - | - |
Free Cash Flow Per Share | 4.07 | -2.89 | -89.71 | -108.26 | - | - |
Gross Margin | 39.86% | 40.40% | 14.25% | 25.03% | 34.65% | 31.33% |
Operating Margin | 7.49% | 7.65% | -53.44% | -22.44% | -2.73% | -34.48% |
Profit Margin | -2.94% | -5.44% | -99.44% | -17.65% | -4.72% | -32.67% |
Free Cash Flow Margin | 3.21% | -2.10% | -31.29% | -27.27% | - | - |
EBITDA | 724.38 | 742 | -5,010 | -2,559 | - | - |
EBITDA Margin | 9.23% | 9.52% | -50.09% | -19.17% | - | - |
D&A For EBITDA | 136.12 | 146 | 336 | 436 | - | - |
EBIT | 588.26 | 596 | -5,346 | -2,995 | -389 | -3,223 |
EBIT Margin | 7.49% | 7.65% | -53.44% | -22.44% | -2.73% | -34.48% |